Testing effectiveness (Phase 2)Looking for participantsNCT07779408
What this trial is testing
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Who this might be right for
Healthy VolunteersInfluenza
Sanofi 640